Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer
- 1 May 2007
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 20 (5), 538-544
- https://doi.org/10.1038/modpathol.3800769
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Erratum: TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohortOncogene, 2007
- TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohortOncogene, 2007
- TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate CancerCancer Research, 2006
- Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with RearrangementNeoplasia, 2006
- Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancerGenes, Chromosomes and Cancer, 2006
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Radical Prostatectomy versus Watchful Waiting in Early Prostate CancerNew England Journal of Medicine, 2005
- Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptomeOncogene, 2005
- Relational Database Structure to Manage High-Density Tissue Microarray Data and Images for Pathology Studies Focusing on Clinical Outcome: The Prostate Specialized Program of Research Excellence ModelThe American Journal of Pathology, 2001
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998